Aerie Pharmaceuticals (AERI) Stock Analysis

What Aerie Pharmaceuticals does

Aerie Pharmaceuticals, Inc. operates as a pharmaceutical enterprise focused on the discovery, development, and commercialization of ophthalmic treatments for the U.S. market. The company's therapeutic scope includes open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration. Its commercialized portfolio features Rhopressa, a once-daily eye drop designed to lower elevated intraocular pressure (IOP) for patients with open-angle glaucoma or ocular hypertension. Also available is Rocklatan, a daily fixed-dose combination of Rhopressa and latanoprost, which similarly works to reduce IOP in individuals with these conditions. In its development pipeline, Aerie is advancing AR-15512 to address the symptoms and signs of dry eye, alongside AR-1105 and AR-14034 SR, which are sustained-release implants targeting various retinal diseases. The company also engages in a collaborative research, development, and licensing agreement with DSM Biomedical. Established in 2005, Aerie Pharmaceuticals, Inc. is headquartered in Durham, North Carolina.

Key metrics

ETFs linked to AERI

Broad-market and Healthcare sector ETFs an investor holding Aerie Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how AERI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Aerie Pharmaceuticals?

Aerie Pharmaceuticals trades under the ticker AERI on NASDAQ.

Which exchange is AERI listed on?

AERI is listed on NASDAQ.

What sector does Aerie Pharmaceuticals operate in?

Aerie Pharmaceuticals is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

How can PortView help analyze AERI in a portfolio?

PortView shows AERI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.